Introduction: Thyroid dysfunction is associated with mortality in critically ill patients. We investigated the predictive value of the thyroid hormone compared to CRP in septic patients.
Introduction
Sepsis, an infection induced systemic inflammation with deleterious host response to the pathogen, may often progress to severe sepsis and finally to septic shock. Severe sepsis leads to acute organ dysfunction secondary to documented or suspected infection; the condition may progress to septic shock when hypotension develops that cannot be reversed with fluid resuscitation. Therefore, severe sepsis and septic shock are recognized as major health concerns worldwide with increasing incidence. Millions of people are affected around the world each year, (killing one in four and often more) [1] .
The assessment of infection response to antibiotics relies mostly on the evolution of the same criteria used for diagnosis [2] . Microbiological criteria are also of little help in the assessment of response because of the long time needed to obtain culture results. These uncertainties in the clinical decisionmaking process have led investigators to study the inflammatory cascade for potential objective markers of infection. These biomarkers, could be used as surrogates of infection diagnosis; C-reactive protein (CRP) is one of the most studied biomarkers in this regard [3] , It has already been shown how a single CRP measurement can help in the diagnosis of infection [4] ; however there are some controversies concerning prognosis. Furthermore, the serial determinations have also been found to be useful in predicting infection as well as in monitoring its response to treatment [5] .
Abnormal ''thyroid function test" results have often been noticed in patients suffering from various infections, because the thyroid hormone plays an important role in the adaptation of metabolic function to stress and critical illness. Such alterations in thyroid hormone levels are referred to as ''nonthyroidal illness syndrome (NTIS)", characterized by low serum levels of free and total triiodothyronine (T3) and high levels of reverse T3 (rT3) accompanied by normal or low levels of thyroxin (T4) and thyroid-stimulating hormone (TSH). NTIS can be attributed to increased deiodination of thyroxine (T4) to reverse T3 (rT3), rather than T3 and increased catabolism of T3 to 3, 3diiodothyronine (T2) [6] . With increasing severity of illness, low total and free T4 and sometimes low TSH can be observed [7] . Thyroid dysfunction has also been found to be associated with the mortality of patients admitted to the ICU [8] .
Therefore, thyroid hormone is also an important predictor in the mortality in patients with sepsis. The magnitude of the thyroid function test result abnormalities seems to depend on the severity and duration of illness, rather than the type of illness [9] .
Researchers in some studies demonstrated that free triiodothyronine (FT3) levels in non survivors were significantly lower than those in survivors in acute respiratory distress syndrome and prolonged mechanical ventilation [10] , whereas other researchers showed that there was no association between FT3 levels and ICU patient outcomes [11] . Conflicting results also were reported in terms of other indicators, such as FT4 and TSH [12] .
Here we investigated the relation between thyroid hormone and mortality in patients with sepsis, severe sepsis and septic shock in comparison with C reactive protein.
Patient and methods
This prospective study was conducted in several Critical Care Units of Kasr Al-Ainy Hospital, Cairo University. A total of eighty patients, who were admitted to ICU with sepsis during the period from October 2013 to March 2014, were included.
The patients were categorized into three groups: (i) sepsis group included 36 patients with culture-proven or visually identified infection accompanied by two or more of the follow-ing abnormalities (temperature >38.5°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min or PaCO 2 <32 mmHg and TLC count >12,000 cells/mm 3 , <4000 cells/mm 3 , or >10 percent immature (band) forms; (ii) severe sepsis group included 23 patients with sepsis accompanied by organ failure or hypoperfusion (including oliguria and altered mental status); (iii) septic shock group included 21 patients with severe sepsis accompanied by hypotension (systolic blood pressure <90 mmHg or a fall off >40 mmHg from the baseline in the absence of other causes of hypotension).
Patients with the following criteria were excluded from our study: (i) history of any thyroid diseases such as hyperthyroidism, hypothyroidism, thyroid tumors, and thyroid nodule discovered by clinical examination on admission to the ICU; (ii) pregnancy within the previous six months; (iii) intake of drugs altering thyroid functions such as amiodarone, dopamine, and phenytoin.
Data collection
Medical history with a special emphasis on the history of drug intake or any thyroid disease of all patients was recorded. All patients are subjected to full clinical examination including vital signs assessment (heart rate, respiratory rate, blood pressure, and temperature). Pan Cultures (blood, sputum, urine or other suspected sites of infection) were collected on admission.
Blood samples were collected from each participant on the day of admission (D1) and fifth day after admission (D5) for free triiodothyronine (FT3), free thyroxine (FT4), thyroidstimulating hormone (TSH), and C-reactive protein (CRP); IL-6 was also determined on the day of admission. Informed consent was obtained from the patient or his relatives. All patients were followed up until discharge or death. Finally, the patients were again divided into two groups: survivors and non survivors.
Measurements
Thyroid function tests (FT3, FT4 and TSH) were performed in Chemical Pathology Unit, Kasr Al-Ainy Hospital on ELISA Reader Stat Fax -2100 using Enzyme Immunoassay Kits supplied by BioCheck (323 Vintage Park Drive Kits Foster City, CA 94404).
Following are the normal ranges of serum hormone concentrations: FT3 = 1.7-4.5 pmol/L, FT4 = 0.8-2 pmol/L, and TSH = 0.3-5.50 mIU/L. Serum creatinine and albumin levels were determined using chemistry auto analyzer (Hitachi 917) using Roche Diagnostics Kits. Serum CRP was measured using the kits supplied by Teco Diagnostics (1268 N. Lakeview Ave. Anaheim, CA 92807 USA. Serum IL-6 was measured using Human IL-6 ELISA kit supplied by Ani Biotech (Orgenium Laboratories Business Unit).
Scoring systems
Our study included the calculation of scoring systems: Acute Physiology and Chronic Health Evaluation (APACHE) II and sequential organ failure assessment (SOFA) scores. They allow an assessment of the severity of disease and provide an estimate of in-hospital mortality.
A-APACHE score
The APACHE score is a severity-of-disease classification system, one of several ICU scoring systems. It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): an integer score from 0 to 71 is computed based on several variables: temperature, mean arterial pressure, heart rate, respiratory rate oxygenation, arterial PH, serum sodium, serum potassium serum creatinine, hematocrite, white blood cell and Glasgow coma score.
Each variable is weighted from 0 to 4; with higher scores corresponding to more severe diseases and a higher risk of death. A score of 25 represents a predicted mortality of 50% and a score of over 35 represents a predicted mortality of 80%.
B-SOFA score
The SOFA score was developed during a consensus conference organized by the European Society of Intensive Care and Emergency Medicine The SOFA score calculates a summary value for the degree of dysfunction of six sets of organs: respiratory (po2/fio2), coagulation (platelets), liver (bilirubin), cardiovascular (mean arterial pressure or administration of vasopressors), central nervous system (Glasgow coma scale), and renal (creatinine or urine output). Four levels of dysfunction are identified for each of the organ systems in the SOFA score (184). In this study, SOFA scores were calculated every 48 during the hospital stay.
Statistical analysis
Pre-coded data were entered on the computer using ''Microsoft Office Excel Software" program (2010) for windows. Data were then transferred to the Statistical Package of Social Science Software (SPSS) program, version 21 (SPSS) to be statistically analyzed.
Data were summarized using mean and standard deviation for quantitative variables and frequency, while percentage for qualitative ones. Comparison between the studied groups was performed using independent sample t-test for quantitative variables and Chi square or Fissure exact test for qualitative ones.
Repeated measurements were tested through paired t-test or repeated measures ANOVA test, when suitable, in each group separately.
Relative percent change was calculated as follows:
Pearson correlation coefficients were calculated to signify the associated between different quantitative variables in each group separately. Kaplan-Meier test was performed to obtain the median survival time. Receiver operating characteristics (ROC) curve analysis was conducted to explore the discriminant ability of different parameters to differentiate the non survivors. p values less than 0.05 and 0.01 were considered statistically significant and highly significant, respectively.
Results
Total eighty patients, meeting the inclusion criteria, were prospectively studied. Among them 60 were male (75%) and the rest were female (25%). The mean age of the patients was 55.8 ± 17.0 years, ranging 20-86 years. The primary sources of sepsis were chest and abdomen (47.5%, 25.0%, respectively). The four most common isolated microorganisms were Klebsiella (14.8%), Escherichia coli (12.4%), methicillin resistant Staphylococcus aureus (12.4%) and Pseudomonas (11.8%).
Laboratory investigations

Thyroid hormone levels
On admission, FT3 level within the normal range (1.7-4.5 pg/ml) was found in 41 patients (51.2%), while the other 39 patients (48.8%), had a FT3 level below the lower reference range. FT4 level within the normal reference range of (0.8-2 pmol/L) was found in 53 patients (66.2%), while 27 patients (33.8%) had fT4 levels below the lower reference range. TSH levels within the normal reference range (0.3-5.5 uIU/ml) was found in 58 patients (72.5%), while 22 patients (27.5%) had TSH levels below the lower reference range.
On the fifth day FT3, fT4 and TSH levels below the reference range were found in 61.3%, 31.2% and 23.8% of patients respectively. There was highly significant difference between low levels of FT3 on admission and the fifth day (p < 0.001).
Level of FT3
We compared thyroid hormone levels among the patients of three studied groups (sepsis, severe sepsis, and septic shock) and found that the mean level of FT3 was lower in patients with septic shock (1.3 ± 0.4 pg/ml) and severe sepsis (1.7 ± 0.2 pg/ml) as compared to patients with sepsis (2.4 ± 1.2 pg/ml) with p value <0.001. However, no significant difference was observed in the mean levels of FT4 and TSH among these studied groups (Table 1) .
ICU mortality
The patients were followed up until discharged or death and based on the outcome, they were divided into two groups: survivors (included 41 patients) and non survivors (included 39 patients). We found a significant difference in the mean ages of the patients between these two groups (survivor group: 46.3 ± 13.8 years, non survivor group: 65.7 ± 14.2 years; p < 0.001).
There were 34 males and seven females in the survivor group, while non survivors included 26 males and 13 females; statistically no significant difference in gender distribution was observed between the groups (p = 0.1) ( Table 2 ). In survivors, there were 36 patients (87.8%) with sepsis, 4 patients (11.2%) with severe sepsis and one patient (1.8%) with septic shock. In non survivors, there were 18 patients (46.2%) with severe sepsis and 21 patients (53.8%) with septic shock, but there were no patients with sepsis. There was high significant difference between both groups (p < 0.001).
Microbiological analysis of both groups
There were several sources of infection (chest, abdomen, urine, etc). The abdominal infection was the only source that showed statistical significant difference between survivors and non survivors (p = 0.04). It was diagnosed in fourteen patients of non survivors (35.9%) and in six patients of survivors (14.6%).
As regarding the causative organism, methicillin resistant S. aureus (MRSA) infection was higher in non survivors as compared with survivors. There was high = statistical significant difference between both groups (p = 0.009). It was diagnosed in ten patients of non survivors (29.4%) and two patients of survivors (5.1%) ( Table 3 ).
Hematological and biochemical parameters
We found lower hemoglobin and albumin levels, but higher TLC (total leukocyte count) among non survivors when compared with survivors (Table 4 ).
No significant difference was found in the mean levels of the thyroid hormone on D1 as well. During follow up, we observed a significant increase in the mean FT3 level among survivors, but a decrease among non survivors (p < 0.001); however, other thyroid function tests did not show any significant difference between both groups ( Table 5 ).
High significant difference in the percentage change between FT3 on D1 and D5 was observed between the two groups (survivors: 53.8 ± 56.8, non survivors: 45.8 ± 19.9; p < 0.001); however, there was no significant difference in the percentage changes of FT4 and TSH between both groups (p = 0.1 and 0.6, respectively) ( Table 6 ). While no significant difference was found in median CRP level (p = 0.3) on D1, high significant difference was observed in the median CRP level (p < 0.001) on D5 with non survivors showing a higher value.
Interleukin-6 (IL-6) level was used as a marker of inflammatory response. All patients showed high interleukin 6 (IL6) confirming sepsis. The mean level of IL6 on admission was higher in non survivors than survivors, and a highly significant difference was found between two groups (p < 0.001) ( Table 7) .
ICU mortality calculator: APACHE and SOFA scores
The mean APACHE (Acute Physiologic and Chronic Health Evaluation) and SOFA (Sequential Organ Failure Assessment) scores were higher in non survivors than survivors. There was highly significant difference between both groups (p < 0.001). The median estimate survival time among the septic patients was 20 days (ranging between 15.1 days and 24.9 days) with 95% confidence interval (CI) ( Table 8 ).
There was highly significant difference in the duration of MV and ICU stay between survivors and non survivors (p < 0.005 and 0.001 respectively) ( Table 9 ).
Correlation between FT3 on D5 with other parameters within non survivors
We found significant negative correlations between FT3D5, CRP, IL-6, APACHE and SOFA scores. In addition, FT3 levels on D5 were also negatively correlated with the duration of mechanical ventilation and ICU stay ( Table 10) .
Receiver operating characteristic (ROC) curves were constructed to examine the performance of indicators as predictors of ICU mortality; the area under the curve (AUC) for each indicator was calculated. In the case of thyroid function tests, the FT3 D5 level with largest AUC (0.855) was the best in predicting ICU mortality (p < 0.001, sensitivity 87.2%, and specificity 73.2%).
CRP (AUC = 0.984, p < 0.001, sensitivity 100%, and specificity 92.7%) emerged as a better tool than IL-6 (AUC = 0.934, p < 0.001, sensitivity 92.3%, and specificity 80.5%) for predicting the mortality in septic patients.
Between the two scoring systems, we found the SOFA score (AUC = 1, p < 0.001, sensitivity 100%, and specificity 100%) was the better tool for predicting the mortality in septic patients than the APACHE score (AUC = 0.975, p < 0.001, sensitivity 94.4%, and specificity 92%) ( Table 11 and Figs. 1 and 2 ).
Discussion
The role of euthyroid sick syndrome (ESS) as a predictor of poor outcome in sepsis and critical illness remains unclear. This inspires us to undertake the current study on septic patients to assess the relation between thyroid function tests, CRP, IL-6, and ICU mortality scores (APACHE and SOFA scores) as predictors of mortality.
We first divided 80 enrolled patients into three groups as sepsis (36 patients), severe sepsis (23 patients), and septic shock (21 patients) groups. Based on the outcome of the follow-up, these 80 patients were again divided into two groups as survivors (41 patients) and non survivors (39 patients).
Our biomarker data did not show any difference in circulating thyroid hormone levels (FT3, FT4 and TSH) measured on admission among survivors and non-survivors, thus, failed to provide any helpful prognostic information. During follow up (D5), only the mean FT3 was significantly decreased in non survivors (1 ± 0.65 pg/ml), while it increased in survivors (2.9 ± 1.03 pg/ml) (p < 0.001). The mean serum FT3 was lower in patients with septic shock (1.3 ± 0.4 pg/ml) and severe sepsis (1.7 ± 0.2 pg/ml) as compared to patients with sepsis (2.4 ± 1.2 pg/ml), while other thyroid indicators did not show any significant difference. Meyer et al. [13] assessed the prognostic accuracy of thyroid hormone levels in 103 septic patients on admission and during follow up and found no difference in FT3 and FT4 levels on admission in non survivors when compared with survivors. The lowest FT3 level was found in patients with severe sepsis (0.8 nmol/l) and septic shock (0.8 nmol/l), which is in agreement with our findings. However, in the same study during follow up, they found that the FT4 level decreased significantly in non survivors, while it increased in survivors (p 0.003); our findings differ in this regard and the difference could be attributed to the time of measurement of the thyroid hormone, Meyer et al. measured the thyroid hormone on admission, the second day and at discharge, while the thyroid hormone was measured on admission and fifth day in this study.
In a systematic review on association between thyroid function tests at the baseline and the outcome of patients with sepsis or septic shock, Anna et al. [14] included nine studies, all having a prospective cohort design. Seven of those studies involved children, while two involved adults. Six of the nine included studies disagreed with our results and showed that FT3 and FT4 on admission were lower in patients with sepsis who had an unfavorable outcome than in those who had a favorable outcome, while the remaining studies came in agreement with our results. They concluded that FT3 and FT4 levels on admission are not helpful in predicting outcome in sepsis. In our study, low FT3 level on the fifth day was the only independent predictor of mortality among the thyroid function tests, as indicated by the largest AUC of 0.855. The AUC for the FT3 level (0.855) was less than that for APACHE (0.975) and SOFA scores (1.00). We found a significant negative correlation between FT3 on D5 and ICU predicting mortality scores (FT3 on D5 and APACHE score, p = 0.025; FT3 on D5 and SOFA score, p = 0.007). We suggest that the addition of the FT3 level to the APACHE II and SOFA scores might improve the ability to predict ICU mortality.
Wang et al. [15] investigated the relation between the thyroid hormone and APACHE in 480 critical illness patients including sepsis, and reported similar findings as observed by us. They found that FT3 was the best among the thyroid hormone indicators for predicting ICU mortality, as suggested by the largest AUC of 0.762. The AUC for the FT3 level was less than that for APACHE II score (0.829 ± 0.022). The level of FT3 was significantly correlated with the APACHE score (p < 0.001). Ture et al. [16] measured thyroid hormones within the first 24 h in 206 patients with acute respiratory distress syndrome and found that serum FT3 concentrations markedly decreased after ICU admission among non survivors. There was high significant and negative correlation between FT3and ICU mortality scores (for APACHE II score p < 0.0005 and for SOFA scores p < 0.0005).
Our study is in agreement with the findings by Elvio et al. [17] , who studied 32 consecutive patients with respiratory failure including pneumonia and observed that plasma fT3 was correlated with PaO2/FiO 2 (p = 0.001) and APACHE II score (p = 0.003). Among non survivors, FT3 levels were significantly lower (p = 0.002) compared to the survivors.
We observed that the mean CRP increased significantly from D1 to D5 in non survivors (from 53.9 ± 50 mg/l to 162.2 ± 55 mg/l), while it decreased significantly from D1 to D5 in survivors (from 63.8 ± 48 mg/l to 19.1 ± 25.7 mg/l) with a high significant difference (p < 0.001). This suggests that decreasing or increasing values of CRP may be used as a predictor of outcome in patients with sepsis. In this regard, the findings by Povoa et al. [3] are in agreement with our findings. They studied 891 consecutive patients of community acquired sepsis and found that CRP was significantly higher in non survivors. In another study by Povoa et al. [18] , the daily C-reactive protein measurement after antibiotic prescription was found to be useful in identifying ventilator-associated pneumonia (VAP) patients with poor outcome.
In the present prospective study, all patients showed high interleukin-6 (IL-6) levels, confirming sepsis. Non survivors had higher IL-6 levels (231.3 ± 178.4 pg/ml) as compared to survivors (35.7 ± 34.7 pg/ml).There was high significant difference between both groups (p < 0.001), suggesting that the IL-6 level can be used as a marker for diagnosis and prognosis of sepsis. Figure 1 The ROC curve of FT3D5.
Figure 2
The ROC curve of APACHE, SOFA scores, CRP and IL-6.
In their study, Zhenyu et al. [19] divided 102 patients with sepsis into survival and non survival groups. Serum IL-6 level was measured on admission to ICU. The authors found that serum IL-6 levels of patients in the non survival group of sepsis were significantly higher than those in the survival group (p < 0.01).
We observed lower FT3 on day 5 with higher CRP and IL-6 in non survivors and FT3 D5 level was also negatively correlated with CRP (p = 0.039) and IL-6 (p = 0.035). The AUC for FT3 (0.855) was less than for CRP (0.984) and IL-6 (0.934). Hence, the FT3 had less ability than IL-6 and CRP in predicting mortality in sepsis.
Our findings are also in accordance with the results obtained by Dilli and Dilmen [20] . They determined the relation between FT3, CRP and IL-6 levels in 148 infants with sepsis. The Serum FT3 was negatively and strongly correlated with IL-6 (r = À0.49, p = 0.001) and CRP (r = À0.33, p = 0.03). The mortality rate was higher among infants with lower FT3 levels. This can be explained based on the fact that CRP is induced by cytokines (especially by IL-6) and produced in the liver, whereas iodothyronine5 0 -deiodinase, mediating the conversion of T3 from T4, is also found in rich quantities in the liver. It is possible that IL-6 stimulates the production of CRP as well as inhibits5 0 -deiodinase.
Our results suggest that FT3 level is the only predictor of mortality among all components of the thyroid hormone. We found CRP, an inflammatory mediator, showing a significant prognostic value in predicting the mortality in septic patients when compared to that in IL-6 and FT3 levels.
The current study has a few limitations. Firstly, we measured serum IL-6 levels only on the day of admission; follow up of IL-6 might have improved validity of the results. Secondly, patients in ICU receive many drugs that may affect the level of the thyroid hormone; twenty five patients, who were excluded from this study, fifteen of them received dopamine, while the rest received amiodarone and phenytoin.
Conclusions and recommendation
The objective of our study was to find whether the thyroid hormone has any prognostic value in predicting mortality among sepsis patients. FT3 measured on fifth day of admission came out as the only independent predictor of ICU mortality. Although SOFA score was the best predictor of mortality followed by APACHE score, CRP, tIL-6 levels, and FT3 D5, we still recommend FT3 to be used as a predictor of mortality in sepsis as this is the only independent predictor for ICU mortality.
